loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Halazepam

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Halazepam

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Schering's Peginterferon Alfa-2B Receives Approval in US
    Schering's Peginterferon Alfa-2B Receives Approval in US

    08 Jan 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949

    FDA
    08 Jan 2019
    Share Share
    Schering's Peginterferon Alfa-2B Receives Supplemental Approval in US
    Schering's Peginterferon Alfa-2B Receives Supplemental Approval in US

    21 Dec 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949

    FDA
    21 Dec 2018
    Share Share
    Schering's Peginterferon Alfa-2B Receives Supplemental Approval in US
    Schering's Peginterferon Alfa-2B Receives Supplemental Approval in US

    21 Dec 2018

    //

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103949

    21 Dec 2018
    Share Share